FORMAC strengthens management with appointment of CSO and COO
FORMAC Pharmaceuticals N.V. announced that Filip Kiekens will become the company’s new Chief Scientific Officer and that Laurent Schueller will become the company’s new Chief Operating Officer.
Filip Kiekens, Chief Scientific Officer
Dr. Filip Kiekens joins FORMAC from the Pharmaceutical Development Division of Johnson & Johnson (JANSSEN Pharmaceutica NV), where he led early and late development projects with increasing responsibilities. During his extensive research and development of complex active compounds, he was recognized with the JNJ Standards of Leadership award and the Philip B. Hofmann Research Scientist Award. For the successful development of INTELENCE®, a novel HIV drug, he was awarded the Johnson Medal, the most prestigious award given to scientists and technologists in Johnson & Johnson. As one of the Flanders District of Creativity Fellows, Filip merges his scientific passion of formulating complex molecules with his entrepreneurial spirit into business opportunities.
Filip graduated as a pharmacist in 1995 and holds a Ph.D. in Pharmaceutical Technology from the University of Ghent, Belgium.
Laurent Schueller, Chief Operating Officer
Dr. Laurent Schueller joins FORMAC Pharmaceuticals N.V. from Tibotec, where he was Chemical & Pharmaceutical Team Leader for the development of 2 late stage programs for the treatment of tuberculosis (TMC207) and HIV (TMC114). He was also involved in defining outsourcing strategies for the pharmaceutical development projects of Johnson and Johnson. Prior to his responsibilities in drug development, Laurent was responsible for budget management & control of a diverse portfolio of early and late development drugs. At FORMAC, Laurent will be responsible for the drug development programs and the associated operational activities.
Laurent graduated as a Pharmacist from the University of Strasbourg, France and holds a Ph.D. in Pharmaceutical Technology from the University of London, UK. He obtained his MBA from the Vlerick Business School in Belgium.
Other news from the department people
Most read news
More news from our other portals
Last viewed contents
Experimental drug shows promise against brain, prostate cancers
Right under your nose: A more convenient way to diagnose Alzheimer's disease - Certain proteins in nasal discharge can indicate the onset and progression of Alzheimer's, providing an avenue for early detection
A bright spot for microbiological diagnostics - Researchers develop molecular probes to detect pathogens in clinical samples
New findings on the enzyme that breaks down PET plastic - Scientists increase efficiency: Start-up company in preparation
"Growing end" of inflammation discovered - Stopping chronic inflammatory diseases
Nanoscale ruler reveals organization of the cell membrane - Freiburg biologists measure distances and the arrangement of membrane molecules in nanometer range
How plants control their active ingredients epigenetically - A new study shows how the production of pharmaceutically relevant substances in nightshade plants works and is regulated epigenetically
Largest ever epigenetics project launched
